ONEai Health
OperatingHealth Magnet Holdings, Inc.
Healthcare · Wesley Chapel, FL
Chronic conditions shouldn’t mean constant worry. ONEai Health uses advanced AI to continuously analyze personal biometric readings, seamlessly supporting individuals, caregivers, and healthcare teams, whether at home, after a hospital stay, or in daily life. It keeps watch over key health indicators, offering near real-time insights and smart predictions to help detect potential issues early so individuals and providers can take action before problems escalate. We aim to achieve fewer emergency department visits, lower costs, and greater peace of mind for patients and healthcare professionals alike, this is the future of intelligent, continuous health monitoring.
Financials
FY2023–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps markedA dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Team
14 people
Clinton, a University of Michigan Law and Cornell graduate, is a leading healthcare law expert and educator. A Partner at The Health Law Partners, he advises industry leaders and has earned national recognition, including the Burton Award. He’s a sought- after speaker and ABA leader shaping healthcare law.
Rob Fisher served in several pivotal roles such as Chief Business Development Officer, Chief Nurse Officer, and Vice President for the Cardiovascular/Neuroscience/ Telehealth Network. Rob left an indelible mark by spearheading initiatives like the Michigan Stroke Network, a revolutionary model for acute stroke care, which garnered nationwide adoption.
Dr. Fessler specializes serves as the Specialist-in-Chief of Neurosurgery at the Detroit Medical Center and Chief of Neurosurgery at DMC Detroit Receiving Hospital. As a member of the prestigious Michigan Head and Spine Institute, Dr. Fessler specializes in complex vascular abnormalities of the brain, neck, and spinal cord for the treatment of aneurysms, carotid artery disease, and stroke
Stephen Thornhill brings over a decade of expertise in organizational performance focused on developing and managing digital media products, including healthcare innovations like the Leapfrog Hospital Safety Grade and evaluation applications for surgical residents, and many more. A 40 Under 40 honoree and Harvard-educated leader, Stephen is a skilled operator who excels in enhancing user experience and leading global teams at ONEai Health.
Dr. Angel Iscovich, Chairman of the Advisory Board at ONEai Health, brings extensive experience as a healthcare executive and CEO of Inflexion, also serving as CEO of Envision Healthcare’s largest division and advising Baleon Capital and Potentia Analytics in healthcare technology.
Growth Adviser and continuous improvement expert for mid-sized companies and private equity firms who are revitalizing underperforming portfolio companies, navigating M&A integrations, or seeking to seize substantial market opportunities through a well-crafted growth strategy.
Show 5 more peopleShow fewer
Andrea is a seasoned healthcare professional with 33 years of invaluable healthcare experience with healthcare systems, community hospitals, and ambulatory facilities, providing her with a comprehensive understanding of the intricacies of healthcare administration.
Dave Vort is an experienced leader in commercial strategy and market expansion with 25+ years in the medical device sector. He is currently the Chief Commercial Officer of Cytovale. He was President of Magnus Medical, where he led the commercialization of brain stimulation tech for depression.
Jason Napierala, with 33 years in the healthcare industry, is a licensed Nursing Home Administrator at Blue Creek Healthcare. His extensive experience spans Medicare, nursing, and long-term care, with executive roles at facilities like Indian Meadows Nursing Center and Trilogy Health Services.
I am the Managing Partner of The Barbeau Group, an investment and management firm based in Quebec, Canada, and Pompano Beach, Florida. We specialize in technology, medical devices, energy, and manufacturing, leveraging strategic expertise to drive growth, innovation, and long-term value across multiple industries.
Dr. McCullough is recognized internationally as a leading figure in the study of chronic kidney disease as a cardiovascular risk state, having over 1,000 publications to his name and over 500 citations in the National Library of Medicine. His works include “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” - the first widely utilized treatment regimen for ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine. He has dozens of peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in The Hill, America Out Loud, and on FOX NEWS Channel. He has had years of dedicated academic and clinical efforts in combating the SARS-COVID virus and in doing so, has reviewed thousands of reports, participated in scientific congresses, group discussions, press releases, and has been considered among the world's experts on COVID-19. “As a medical specialist and researcher dedicated to advancing the prevention and management of chronic disease, I wholeheartedly endorse ONEai Health’s AI-powered continuous monitoring system for heart failure. Utilizing wearable technology and advanced machine learning, ONEai enables early detection and proactive interventions, preventing hospital readmissions and improving patient outcomes. I am excited to lead and advise in further developing AI solutions for the prevention and management of common diseases, helping millions receive the continuous, compassionate care they deserve.” — Dr. Peter A. McCullough, MD, MPH
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 1 annual reports (FY2025)
Missing: 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.